Literature DB >> 35763218

Patients with Chromosome 11q Deletions Are Characterized by Inborn Errors of Immunity Involving both B and T Lymphocytes.

Elise J Huisman1,2, A Rick Brooimans3, Samone Mayer1, Marieke Joosten4, Louis de Bont5, Mariëlle Dekker6, Elisabeth L M Rammeloo7, Frans J Smiers8, P Martin van Hagen3,9, C Michel Zwaan10,11, Masja de Haas12,13,14, Marjon H Cnossen1, Virgil A S H Dalm15,16.   

Abstract

Disorders of the long arm of chromosome 11 (11q) are rare and involve various chromosomal regions. Patients with 11q disorders, including Jacobsen syndrome, often present with a susceptibility for bacterial and prolonged viral and fungal infections partially explained by hypogammaglobulinemia. Additional T lymphocyte or granular neutrophil dysfunction may also be present. In order to evaluate infectious burden and immunological function in patients with 11q disorders, we studied a cohort of 14 patients with 11q deletions and duplications. Clinically, 12 patients exhibited prolonged and repetitive respiratory tract infections, frequently requiring (prophylactic) antibiotic treatment (n = 7), ear-tube placement (n = 9), or use of inhalers (n = 5). Complicated varicella infections (n = 5), chronic eczema (n = 6), warts (n = 2), and chronic fungal infections (n = 4) were reported. Six patients were on immunoglobulin replacement therapy. We observed a high prevalence of low B lymphocyte counts (n = 8), decreased T lymphocyte counts (n = 5) and abnormal T lymphocyte function (n = 12). Granulocyte function was abnormal in 29% without a clinical phenotype. Immunodeficiency was found in patients with terminal and interstitial 11q deletions and in one patient with terminal 11q duplication. Genetically, FLI1 and ETS1 are seen as causative for the immunodeficiency, but these genes were deleted nor duplicated in 4 of our 14 patients. Alternative candidate genes on 11q may have a role in immune dysregulation. In conclusion, we present evidence that inborn errors of immunity are present in patients with 11q disorders leading to clinically relevant infections. Therefore, broad immunological screening and necessary treatment is of importance in this patient group.
© 2022. The Author(s).

Entities:  

Keywords:  B lymphocyte function; Children; Chromosome 11q; Granulocyte function; Hypogammaglobulinemia; Inborn errors of immunity; Jacobsen syndrome; Primary immunodeficiency; T lymphocyte function

Year:  2022        PMID: 35763218     DOI: 10.1007/s10875-022-01303-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  38 in total

1.  Partial monosomy 10q with partial trisomy 11q due to paternal balanced translocation.

Authors:  K Maruyama; T Koizumi; H Ikeda
Journal:  J Paediatr Child Health       Date:  2001-04       Impact factor: 1.954

2.  11q terminal deletion disorder and common variable immunodeficiency.

Authors:  Gregory Puglisi; Mahesh A Netravali; Andrew J MacGinnitie; Vincent R Bonagura
Journal:  Ann Allergy Asthma Immunol       Date:  2009-09       Impact factor: 6.347

Review 3.  11q terminal deletion and combined immunodeficiency (Jacobsen syndrome): Case report and literature review on immunodeficiency in Jacobsen syndrome.

Authors:  Štefan Blazina; Alojz Ihan; Luca Lovrečić; Tinka Hovnik
Journal:  Am J Med Genet A       Date:  2016-09-08       Impact factor: 2.802

4.  Combined partial trisomy 11q and partial monosomy 10p in a 19-year-old female patient: phenotypic and genotypic findings.

Authors:  Anja Hagen; Arndt Bigl; Dorothea Wand; Eva Klopocki; Raoul Heller; Manuela Siekmeyer; Werner Siekmeyer; Wieland Kiess; Andreas Merkenschlager
Journal:  Am J Med Genet A       Date:  2011-11-03       Impact factor: 2.802

5.  Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study.

Authors:  Isabella Quinti; Annarosa Soresina; Andrea Guerra; Roberto Rondelli; Giuseppe Spadaro; Carlo Agostini; Cinzia Milito; Amelia Chiara Trombetta; Marcella Visentini; Helene Martini; Alessandro Plebani; Massimo Fiorilli
Journal:  J Clin Immunol       Date:  2011-03-02       Impact factor: 8.317

6.  The 11q terminal deletion disorder: a prospective study of 110 cases.

Authors:  Paul D Grossfeld; Teresa Mattina; Zona Lai; Remi Favier; Ken Lyons Jones; Finbarr Cotter; Christopher Jones
Journal:  Am J Med Genet A       Date:  2004-08-15       Impact factor: 2.802

7.  Clinical and molecular characterization of patients with distal 11q deletions.

Authors:  L A Penny; M Dell'Aquila; M C Jones; J Bergoffen; C Cunniff; J P Fryns; E Grace; J M Graham; B Kousseff; T Mattina
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

Review 8.  Jacobsen syndrome.

Authors:  Teresa Mattina; Concetta Simona Perrotta; Paul Grossfeld
Journal:  Orphanet J Rare Dis       Date:  2009-03-07       Impact factor: 4.123

9.  de novo interstitial deletions at the 11q23.3-q24.2 region.

Authors:  Jiasun Su; Rongyu Chen; Jingsi Luo; Xin Fan; Chunyun Fu; Jin Wang; Sheng He; Xuyun Hu; ShuJie Zhang; Shang Yi; Shaoke Chen; Yiping Shen
Journal:  Mol Cytogenet       Date:  2016-05-05       Impact factor: 2.009

10.  The 11q Terminal Deletion Disorder Jacobsen Syndrome is a Syndromic Primary Immunodeficiency.

Authors:  Virgil A S H Dalm; Gertjan J A Driessen; Barbara H Barendregt; Petrus M van Hagen; Mirjam van der Burg
Journal:  J Clin Immunol       Date:  2015-11-14       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.